Author

Gayatri Panda

Indraprastha Institute of Information Technology Delhi

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genomics· 1 Systems Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Organism:human· 1 Research Focus:variant effect prediction· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

Arjun RayiD· 2 shared Abhinav K. JainiD· 1 shared Anmol AnmoliD· 1 shared Anushree MishraiD· 1 shared Bhavana PrasheriD· 1 shared Dhwani Dholakia· 1 shared Disha SharmaiD· 1 shared Kiran Kumar Bokara· 1 shared

Activity by Year

2022-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenomics

Arjun RayORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

GenomicsFrontiers in PharmacologyPeer-reviewedJul 5, 2022

Comprehensive assessment of Indian variations in the druggable kinome landscape highlights distinct insights at the sequence, structure and pharmacogenomic stratum

Gayatri Panda, Neha Mishra, Disha Sharma…·Arjun Ray

This study analyzes Indian genetic variations in the kinome to identify sequence, structural, and pharmacogenomic differences compared to global datasets, highlighting implications for drug safety and adverse reactions.

4 citations

humanwhole-genome sequencing

𝕏 PostBluesky

Systems BiologyBMC Complementary Medicine and TherapiesPeer-reviewedApr 22, 2022

Anti-SARS-CoV-2 potential of Cissampelos pareira L. identified by Connectivity map-based analysis and in vitro studies

Madiha Haider, Vivek Raj Anand, Mohammed Ghalib Enayathullah…·Mitali Mukerji

The paper identifies potential anti-SARS-CoV-2 compounds from Cissampelos pareira L. using connectivity map analysis and in vitro testing, showing high inhibition of viral replication.

22 citations

bulk RNA-seqstatistical model

𝕏 PostBluesky